Person:
ERZİK, CAN

Loading...
Profile Picture

Email Address

Birth Date

Research Projects

Organizational Units

Organizational Unit

Job Title

Last Name

ERZİK

First Name

CAN

Name

Search Results

Now showing 1 - 10 of 21
  • Publication
    Neoadjuvan kemoterapi alan lokal ileri evre meme kanseri hastalarında dolaşımdaki tümör hücresi moleküler analizleri
    (2017-10-26) UĞURLU, MUSTAFA ÜMİT; ERZİK, CAN; PEKER EYÜBOĞLU, İREM; AKKİPRİK M., YUMUK P. F., UĞURLU M. Ü., KOCA S., ERZİK C., ALAN Ö., PEKER EYÜBOĞLU İ., GÜLLÜ AMURAN G., ÖZER S. A.
    Amaç: İzole edilen dolaşımdaki tümör hücrelerinin (CTC) analizi bir "sıvı biyopsi" olarak kanser tedavisinin ve prognozunun öngörülebilmesini sağlayan invaziv olmayan bir kişiye özel tıp uygulamasıdır. Bu çalışmanın amacı neoadjuvan kemoterapi alan lokal ileri evre meme kanserli hastalardan tedavi öncesi ve sonrası periferal kan örnekleri alınarak, CTC moleküler karakterizasyonunu yapmak ve tedaviye verilen yanıt ile ilişkisini ortaya koymaktır. Gereç-Yöntem: Çalışmaya 36 neoadjuvan kemoterapi alan lokal ileri evre meme kanserli hasta dahil edilmiş ve hastalardan tedavi öncesi ve sonrası 10 ml kan örnekleri alınmıştır. CTC izolasyonu, tanımlanması ve moleküler analizlerinde immuno-magnetik temelli AdnaTest kitleri kullanılmış, meme kanseri (GA733-2, Muc-1 ve Her-2, Aktin), EMT (PI3Kα, Akt-2, TWIST1) ve kök hücre (ALDH1) markerları incelenmiştir. Görüntüleme Agilent 2100 Bioanalyzer cihazı kulllanılarak DNA 1000 LabChip ile gerçekleştirilmiştir. CTC pozitifliği ve çalışılan markerlar ile tedaviye yanıt (patolojik tam cevap (PCR) ve rezidual hastalık) açısından anlamlılık, Fisher’s Exact test ile analiz edilmiştir. Bulgular: Otuzaltı hastanın 6'sında (%16,7) tedavi öncesinde CTC pozitifliği saptanmıştır. CTC pozitif olan 6 hastanın 4'ünde kök hücre markeri olan ALDH1 pozitifliği gözlenmiştir (p=0,0245) (Tablo 1). EMT markerlarından PI3Kα ise 3 hastada pozitif bulunmuştur. Hasta takipleri ve tedaviye verilen cevaplar izlenmeye devam etmektedir. Sonuç: Neoadjuvan kemoterapi alan lokal ileri evre meme kanseri hastalarında CTC pozitifliği ve kök hücre markerlarının analizi tedaviye verilecek olan cevabın ve hasta sağkalım oranlarının ön görülebilmesi için önemli bir yöntem olabilir. Çalışmalarımız bu kapsamda devam etmektedir.
  • Publication
    Role of TRF2 and TPP1 regulation in idiopathic recurrent pregnancy loss
    (ELSEVIER SCIENCE BV, 2019) ERZİK, CAN; Pirzada, Rameez Hassan; Orun, Oya; Erzik, Can; Cagsin, Huseyin; Serakinci, Nedime
    Telomeres are the tandem repeats (TTAGGG) present at the ends of the chromosomes that ensure chromosome stability and protect chromosomes from degradation. Telomeres in somatic human cells shorten after every cellular division and are linked to the cellular senescence. In this study we have investigated telomere length and expression of shelterin genes in aborted fetus material from idiopathic recurrent pregnancy losses. Telomere length was measured using Telomere Restriction Fragment Length (TRF) analysis. The gene expression levels for important shelterin complex proteins (TRF1, TRF2, POT1, and TPP1) were determined by Real-time Quantitative Reverse Transcriptase PCR (qRT-PCR). Our results demonstrated down regulation of TRF2 and TPP1 and a strong decline in average telomere length in abort material from women suffering from idiopathic recurrent pregnancy loss. We suggest that shorter telomere length and downregulation of the major shelterin components TRF2 and TPP1 leading to telomere uncapping, might play a critical role in recurrent pregnancy loss. (C) 2019 Elsevier B.V. All rights reserved.
  • PublicationOpen Access
    Protective effects of St. John's wort in the hepatic ischemia/reperfusion injury in rats
    (AVES, 2018-09-28) VELİOĞLU ÖĞÜNÇ, AYLİZ; Atalay, Suleyman; Soylu, Belkis; Aykac, Asli; Ogunc, Ayliz Velioglu; Cetinel, Sule; Ozkan, Naziye; Erzik, Can; Sehirli, Ahmet Ozer
    Objectives: The purpose of this study was to investigate possible protective effects of St. John's wort in the hepatic ischemia/reperfusion injury. Material and Methods: The hepatic artery, portal vein, and bile duct were all clamped for 45 minutes to induce ischemia in rats, and after that reperfusion for 1 hour. SJW was administrated orally, once a day for 3 days before ischemia/reperfusion. The aspartate aminotransferase, alanine aminotransferase, tumor necrosis factor, and interleukin levels were measured in the serum samples. Luminol chemiluminescence, lucigenin luminol chemiluminescence levels; myeloperoxidase. The sodium-potassium ATPase (Na+/K+ ATPase) activity was determined in the liver tissue, and caspase-3 and caspase-9 activity with the bcl-2/bax ratio were measured by the western blot analysis. Results: The St. John's wort administration recovered the aspartate aminotransferase, alanine aminotransferase, tumor necrosis factor, and IL-1 beta levels serum parameters meaningfully, while ischemia/reperfusion caused an increase in luminol chemiluminescence, lucigenin luminol chemiluminescence, myeloperoxidase, caspase-3, and caspase-9 activity and led to a decrease in the B-cell lymphoma-2/bcl-2-associated X protein (bcl-2/bax) ratio and the Na+/K+ ATPase activity. Conclusion: The obtained results indicate protective effects of St. John's wort on the ischemia/reperfusion injury through various mechanisms, and we are able to suggest that St. John's wort can clinically create a new therapeutic principle.
  • PublicationOpen Access
    Effects of Circadian Rhythm Hormones Melatonin and 5-Methoxytryptophol on COXs, Raf-1 and STAT3
    (2018-08-01) ERZİK, CAN; Savtekin, Gokce; Serakinci, Nedime; Erzik, Can; Cetinel, Sule; Sehirli, Ahmet Ozer
  • PublicationOpen Access
    Nesfatin-1 alleviates extrahepatic cholestatic damage of liver in rats
    (ASSOC BASIC MEDICAL SCI FEDERATION BOSNIA & HERZEGOVINA SARAJEVO, 2016-11-10) ERZİK, CAN; Solmaz, Ali; Gulcicek, Osman Bilgin; Ercetin, Candas; Yigitbas, Hakan; Yavuz, Erkan; Arici, Sinan; Erzik, Can; Zengi, Oguzhan; Demirturk, Pelin; Celik, Atilla; Celebi, Fatih
    Obstructive jaundice (OJ) can be defined as cessation of bile flow into the small intestine due to benign or malignant changes. Nesfatin-1, recently discovered anorexigenic peptide derived from nucleobindin-2 in hypothalamic nuclei, was shown to have anti-inflammatory and antiapoptotic effects. This study is aimed to investigate the therapeutic effects of nesfatin-1 on OJ in rats. Twenty-four adult male Wistar-Hannover rats were randomly assigned to three groups: sham (n = 8), control (n = 8), and nesfatin (n = 8). After bile duct ligation, the study groups were treated with saline or nesfatin-1, for 10 days. Afterward, blood and liver tissue samples were obtained for biochemical analyses, measurement of cytokines, determination of the oxidative DNA damage, DNA fragmentation, and histopathologic analyses. Alanine aminotransferase and gamma-glutamyl transferase levels were decreased after the nesfatin treatment; however, these drops were statistically non-significant compared to control group (p = 0.345, p = 0.114). Malondialdehyde levels decreased significantly in nesfatin group compared to control group (p = 0.032). Decreases in interleukin-6 and tumor necrosis factor-a levels from the liver tissue samples were not statistically significant in nesfatin group compared to control group. The level of oxidative DNA damage was lower in nesfatin group, however this result was not statistically significant (p = 0.75). DNA fragmentation results of all groups were similar. Histopathological examination revealed that there was less neutrophil infiltration, edema, bile duct proliferation, hepatocyte necrosis, basement membrane damage, and parenchymal necrosis in nesfatin compared to control group. The nesfatin-1 treatment could alleviate cholestatic liver damage caused by OJ due to its anti-inflammatory and antioxidant effects.
  • Publication
    Role of vagal afferents on high fat diet-induced alterations in rat behaviour and gut motility
    (2017-09-01) ÖZDEMİR KUMRAL, ZARİFE NİGAR; PEKER EYÜBOĞLU, İREM; ERZİK, CAN; ÖZBEYLİ, DİLEK; ÇETİN O., KARATAŞ H. Ö., Akgün B., öztürk y., İMERYÜZ N., ÖZDEMİR KUMRAL Z. N., ÖZBEYLİ D., ARABACI TAMER S., PEKER EYÜBOĞLU İ., ERZİK C., et al.
  • Publication
    The Anti-Inflammatory and Neuroprotective Effects of Ghrelin in Subarachnoid Hemorrhage-Induced Oxidative Brain Damage in Rats
    (MARY ANN LIEBERT, INC, 2010) VELİOĞLU ÖĞÜNÇ, AYLİZ; Ersahin, Mehmet; Toklu, Hale Z.; Erzik, Can; Cetinel, Sule; Akakin, Dilek; Velioglu-Ogunc, Ayliz; Tetik, Sermin; Ozdemir, Zarife N.; Sener, Goeksel; Yegen, Berrak C.
    To elucidate the putative neuroprotective effects of ghrelin in subarachnoid hemorrhage (SAH)- induced brain injury, Wistar albino rats (n=54) were divided into sham-operated control, saline-treated SAH, and ghrelin-treated (10 mu g/kg/d IP) SAH groups. The rats were injected with blood (0.3mL) into the cisterna magna to induce SAH, and were sacrificed 48 h after the neurological examination scores were recorded. In plasma samples, neuron-specific enolase (NSE), S-100 beta protein, TNF-alpha, and IL-1 beta levels were evaluated, while forebrain tissue samples were taken for the measurement of malondialdehyde (MDA), glutathione (GSH), reactive oxygen species levels, myeloperoxidase (MPO), Na+-K+-ATPase activity, and DNA fragmentation ratio. Brain tissue samples containing the basilar arteries were obtained for histological examination, while cerebrum and cerebellum were removed for the measurement of blood-brain barrier (BBB) permeability and brain water content. The neurological scores were impaired at 48 h after SAH induction, and SAH caused significant decreases in brain GSH content and Na+-K+-ATPase activity, and increases in chemiluminescence, MDA levels, and MPO activity. Compared with the control group, the protein levels of NSE, S-100 beta, TNF-alpha, and IL-1 beta in plasma were also increased, while ghrelin treatment prevented all SAH-induced alterations observed both biochemically and histopathologically. The results demonstrate that ghrelin alleviates SAH-induced oxidative brain damage, and exerts neuroprotection by maintaining a balance in oxidant-antioxidant status, by inhibiting proinflammatory mediators, and preventing the depletion of endogenous antioxidants evoked by SAH.
  • Publication
    Familial Mediterranean fever gene (MEFV) mutations and disease severity in systemic lupus erythematosus (SLE): implications for the role of the E148Q MEFV allele in inflammation
    (SAGE PUBLICATIONS LTD, 2015) ERZİK, CAN; Deniz, R.; Ozen, G.; Yilmaz-Oner, S.; Alibaz-Oner, F.; Erzik, C.; Aydin, S. Z.; Inanc, N.; Eren, F.; Bayalan, F.; Direskeneli, H.; Atagunduz, P.
    Objective Observed low prevalence of SLE among familial Mediterranean fever (FMF) patients in several large cohorts suggests a possible protective effect of the MEFV mutations from SLE. In contrast, SLE patient carriers for the common MEFV mutations had rather complex disease expression with an increased frequency of febrile episodes and pleurisy and a decreased renal complication rate. Our aim was to investigate the prevalence of MEFV gene mutations in patients with SLE and their effect on organ involvement in a well-defined group of biopsy-proven SLE nephritis patients. Material and method The prevalence of four MEFV gene mutations (M694V, M680I, V726A and E148Q) was investigated in 114 SLE patients and effect on disease severity was analyzed in patients with biopsy-proven SLE nephritis. Results None of the SLE patients fulfilled the revised Tel-Hashomer criteria. Fourteen of 114 SLE patients (12.2%) were found to carry at least one MEFV mutation. A single patient in the SLE-Nephritis group was compound heterozygous for M694V/M680I mutations and only one patient in the SLE-Mild group was homozygous for E148Q mutation. Carrier frequency was similar to controls in SLE patients (12.2 vs 18.8%, p=0.34). After the exclusion of the less penetrant E148Q mutation, re-analysis revealed an association between exon 10 mutations and SLE nephritis (p=0.050, odds ratio (OR)=4.16, 95% confidence interval (CI)=1.04-16.6). Carrier rate for the E148Q mutation decreased in the SLE group (controls vs. SLE=20/186 vs. 3/114, p=0.08) and E148Q mutation was absent in SLE nephritis (controls vs. SLE nephritis=20/186 vs. 0/47, p=0.016, OR=11.69, 95% CI=0.69-197.13). Conclusions Carrier rate for the studied MEFV mutations was slightly lower in the SLE group, which is in agreement with previous observations that FMF may confer some protection from SLE. Exon 10 mutations were associated with SLE nephritis after the exclusion of the E148Q mutation. The significance of the E148Q as a disease-causing mutation is controversial, and whether E148Q substitution is a polymorphism generally affecting inflammatory pathways is not addressed in the current literature. In this regard, absence of the E148Q mutation in SLE nephritis may serve as a clue for further investigation into its role as a general modulatory polymorphism for inflammation. This clarification is necessary to conclude whether other more penetrant MEFV gene mutations confer susceptibility to nephritis in SLE.
  • PublicationOpen Access
    Association of ERAP1, IL23R and PTGER4 Polymorphisms with Radiographic Severity of Ankylosing Spondylitis
    (2017-01-31) ERZİK, CAN; Ozen, Gulsen; Deniz, Rabia; Eren, Fatih; Erzik, Can; Unal, Ali Ugur; Yavuz, Sule; Aydin, Sibel Zehra; Inanc, Nevsun; Direskeneli, Haner; Atagunduz, Pamir
    Background: Radiographic severity of ankylosing spondylitis (AS) shows such great variance that some patients never develop syndesmophytes throughout the entire disease span, whereas some develop bamboo spine relatively early. Objective: To study the association between ERAP1 , IL23R and PTGER4 single nucleotide polymorphisms (SNPs) and radiographic severity in AS patients. Methods: rs27044 and rs30187 ( ERAP1 ), rs11209032 ( IL23R ) and rs10440635 ( PTGER4 ) SNPs were genotyped in 235 AS patients fulfilling the modified New York criteria. Patients were classified as mild- and severe-AS according to modified Stoke AS spinal score (mSASSS). Mild-AS is defined as having mSASSS of “0” following at least 10 years of disease duration. Severe-AS is defined as having mSASSS of >20 (patients with mild vertebral changes ( i.e. squaring or erosions) were omitted for clear stratification) regardless of disease duration. Results: The genotype distributions and allele frequencies of ERAP1 rs27044 and rs30187, IL23R rs11209032 and PTGER4 rs10440635 SNPs were similar in mild- (n=171, mSASSS=0, 55.6% HLA-B27 positive) and severe-AS patients (n=64, mSASSS=48.5±17.8, 73.4% HLA-B27 positive). After adjustment for clinical differences between groups (gender, disease duration, HLA-B27 and smoking status) by logistic regression analysis, none of the alleles in the investigated SNPs were found to be associated with radiographic severity of AS. Conclusion: In radiographically well-categorized AS patients, ERAP1 rs27044 and rs30187, IL23R rs11209032 and PTGER4 rs10440635 SNPs are not found to be associated with radiographic severity of AS.
  • Publication
    Meme kanserinde miR-140 ve IGFBP-5 ekspresyon düzeyleriArasındaki ilişkinin araştırılması
    (2012-12-13) PEKER EYÜBOĞLU, İREM; EREN, FATİH; ERZİK, CAN; GÜLLÜ AMURAN G., PEKER EYÜBOĞLU İ., HAHOLU A., EREN F., KÜÇÜKODACI Z., ERZİK C., Baloglu H., ÖZER S. A., AKKİPRİK M.